InvestorsHub Logo
Followers 4
Posts 140
Boards Moderated 0
Alias Born 02/29/2012

Re: slazenger7 post# 67259

Saturday, 01/25/2014 12:35:45 PM

Saturday, January 25, 2014 12:35:45 PM

Post# of 75926
I did read it and my take away from it was that it provides a case study of a potential course of action. A pretty good one at that.

Again, "the point" has to do with companies that have CE Mark and FDA approved products. The specific companies being evaluated are irrelevant.

Perhaps taking a harder look at the breast cancer epidemic in the EU and Canada is a better gage of Solos's growth in those markets. Tie this in with the differences in the US and EU/ Canadian healthcare. I bet Solos has been looking hard at this and so has a number of larger companies.

Solos's value just went up pretty high with these accreditations. That is a no brainer.